Company Filing History:
Years Active: 1999
Title: Alexander Gutcait: Innovator in Optically Active Compounds
Introduction
Alexander Gutcait is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of chemistry, particularly in the development of novel optically active compounds. His work has implications for therapeutic applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Gutcait holds a patent for "Optically active 2,3-dihydroimidazo(1,2-C) quinazoline derivatives." This invention relates to novel optically active 3-substituted methyl-5-methylthio-2,3-dihydroimidazo(1,2-C) quinazoline and 3-substituted methyl-2,3-dihydroimidazo(1,2-C) quinazolin-5(6H)-one. The patent outlines the therapeutic use of these compounds, which can include various substituents such as halogen, hydrogen, methoxy, trifluoromethyl, C1-C4 alkyl, nitro, acetyl, cyano, or hydroxy groups, as well as their pharmaceutically acceptable salts.
Career Highlights
Gutcait is affiliated with the National Science Council, where he continues to engage in research and development. His work is characterized by a commitment to advancing scientific knowledge and practical applications in the field of medicinal chemistry.
Collaborations
Throughout his career, Gutcait has collaborated with esteemed colleagues such as Ji-Wang Chern and Hsiu-Wen Liu. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Alexander Gutcait's contributions to the field of optically active compounds exemplify the vital role of inventors in advancing science and technology. His patent work not only highlights his innovative spirit but also underscores the potential for therapeutic applications in medicine.